These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
64 related items for PubMed ID: 9607567
1. High Raf-1 kinase activity protects human tumor cells against paclitaxel-induced cytotoxicity. Rasouli-Nia A, Liu D, Perdue S, Britten RA. Clin Cancer Res; 1998 May; 4(5):1111-6. PubMed ID: 9607567 [Abstract] [Full Text] [Related]
2. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Cheung HW, Ling MT, Tsao SW, Wong YC, Wang X. Carcinogenesis; 2004 Jun; 25(6):881-7. PubMed ID: 14742319 [Abstract] [Full Text] [Related]
3. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells. Huang Y, Sheikh MS, Fornace AJ, Holbrook NJ. Oncogene; 1999 Jun 10; 18(23):3431-9. PubMed ID: 10376521 [Abstract] [Full Text] [Related]
4. Mechanisms of Taxol-induced cell death are concentration dependent. Torres K, Horwitz SB. Cancer Res; 1998 Aug 15; 58(16):3620-6. PubMed ID: 9721870 [Abstract] [Full Text] [Related]
5. Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel. Britten RA, Klein K. Anticancer Drugs; 2000 Jul 15; 11(6):439-43. PubMed ID: 11001384 [Abstract] [Full Text] [Related]
6. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Jazirehi AR, Vega MI, Chatterjee D, Goodglick L, Bonavida B. Cancer Res; 2004 Oct 01; 64(19):7117-26. PubMed ID: 15466208 [Abstract] [Full Text] [Related]
7. Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T. Cancer Res; 1998 Aug 01; 58(15):3331-8. PubMed ID: 9699663 [Abstract] [Full Text] [Related]
8. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Blagosklonny MV, Giannakakou P, el-Deiry WS, Kingston DG, Higgs PI, Neckers L, Fojo T. Cancer Res; 1997 Jan 01; 57(1):130-5. PubMed ID: 8988053 [Abstract] [Full Text] [Related]
9. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment. Zhou Y, Inaba S, Liu J. Int J Oncol; 2006 Jul 01; 29(1):289-95. PubMed ID: 16773211 [Abstract] [Full Text] [Related]
10. Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells. Fang M, Liu B, Schmidt M, Lu Y, Mendelsohn J, Fan Z. Anticancer Res; 2000 Jul 01; 20(1A):103-11. PubMed ID: 10769641 [Abstract] [Full Text] [Related]
11. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. Judson PL, Watson JM, Gehrig PA, Fowler WC, Haskill JS. Cancer Res; 1999 May 15; 59(10):2425-32. PubMed ID: 10344753 [Abstract] [Full Text] [Related]
12. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. Ling YH, Yang Y, Tornos C, Singh B, Perez-Soler R. Cancer Res; 1998 Aug 15; 58(16):3633-40. PubMed ID: 9721872 [Abstract] [Full Text] [Related]
13. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Yang R, Piperdi S, Gorlick R. Clin Cancer Res; 2008 Oct 15; 14(20):6396-404. PubMed ID: 18927278 [Abstract] [Full Text] [Related]
14. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein. Ponnathpur V, Ibrado AM, Reed JC, Ray S, Huang Y, Self S, Bullock G, Nawabi A, Bhalla K. Clin Cancer Res; 1995 Nov 15; 1(11):1399-406. PubMed ID: 9815937 [Abstract] [Full Text] [Related]
15. Apoptosis as a predictor of paclitaxel-induced radiosensitization in human tumor cell lines. Kurdoglu B, Cheong N, Guan J, Corn BW, Curran WJ, Iliakis G. Clin Cancer Res; 1999 Sep 15; 5(9):2580-7. PubMed ID: 10499636 [Abstract] [Full Text] [Related]
16. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines. Ho TF, Peng YT, Chuang SM, Lin SC, Feng BL, Lu CH, Yu WJ, Chang JS, Chang CC. Toxicol Appl Pharmacol; 2009 Mar 01; 235(2):253-60. PubMed ID: 19133282 [Abstract] [Full Text] [Related]
17. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity. Galmarini CM, Falette N, Tabone E, Levrat C, Britten R, Voorzanger-Rousselot N, Roesch-Gateau O, Vanier-Viornery A, Puisieux A, Dumontet C. Br J Cancer; 2001 Sep 14; 85(6):902-8. PubMed ID: 11556844 [Abstract] [Full Text] [Related]
18. Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. Giannakakou P, Poy G, Zhan Z, Knutsen T, Blagosklonny MV, Fojo T. Oncogene; 2000 Jun 22; 19(27):3078-85. PubMed ID: 10871860 [Abstract] [Full Text] [Related]
19. Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells. Reshkin SJ, Bellizzi A, Cardone RA, Tommasino M, Casavola V, Paradiso A. Clin Cancer Res; 2003 Jun 22; 9(6):2366-73. PubMed ID: 12796407 [Abstract] [Full Text] [Related]
20. Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells. Kim SH, Juhnn YS, Song YS. Ann N Y Acad Sci; 2007 Jan 22; 1095():82-9. PubMed ID: 17404021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]